sellNotable cluster of 6
OYLER JOHN sold $10M of ONC
Chief Executive Officer at BeiGene, Ltd.. 40,109 shares at an average of $259.15, traded Mar 6, 2025, filed Mar 7, 2025.
Warning score
70Value
$10M
40,109 shares
Holdings after
0
-100% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001651308-25-000047, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 5, 2025 | AGrant or award Ordinary Shares | +201,084 | $0.00 | $0 | 4,405,895 | Mar 7, 2025 |
| Mar 6, 2025 | MOption exercise Ordinary Shares | +486,161 | $0.50 | $243k | 4,892,056 | Mar 7, 2025 |
| Mar 6, 2025 | MOption exercise American Depositary Shares | +40,109 | $6.50 | $261k | 40,109 | Mar 7, 2025 |
| Mar 6, 2025 | SOpen-market sale American Depositary Shares | -3,500 | $256.91 | $899k | 36,609 | Mar 7, 2025 |
| Mar 6, 2025 | SOpen-market sale American Depositary Shares | -13,598 | $257.92 | $3.5M | 23,011 | Mar 7, 2025 |
| Mar 6, 2025 | SOpen-market sale American Depositary Shares | -8,200 | $258.91 | $2.1M | 14,811 | Mar 7, 2025 |
| Mar 6, 2025 | SOpen-market sale American Depositary Shares | -6,705 | $259.77 | $1.7M | 8,106 | Mar 7, 2025 |
| Mar 6, 2025 | SOpen-market sale American Depositary Shares | -2,906 | $261.08 | $759k | 5,200 | Mar 7, 2025 |
| Mar 6, 2025 | SOpen-market sale American Depositary Shares | -3,400 | $262.03 | $891k | 1,800 | Mar 7, 2025 |
| Mar 6, 2025 | SOpen-market sale American Depositary Shares | -1,700 | $262.97 | $447k | 100 | Mar 7, 2025 |
| Mar 6, 2025 | SOpen-market sale American Depositary Shares | -100 | $264.27 | $26k | 0 | Mar 7, 2025 |
| Mar 6, 2025 | MOption exercise Share Option (Right to Buy)derivative | -1,007,578 | $0.00 | $0 | 6,559,391 | Mar 7, 2025 |
Related signals
Other insiders at BeiGene, Ltd. and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 40Moderate | sell 310b5-1 | ONC BeiGene, Ltd. | Wang Xiaodong director, other | $11M | 41,760 | |
| 70Notable | sell 5 | ONC BeiGene, Ltd. | OYLER JOHN Chief Executive Officer | $10M | 41,210 | |
| 45Moderate | sell 610b5-1 | ONC BeiGene, Ltd. | Wu Xiaobin President, COO & GM China | $14M | 51,921 | |
| 70Notable | sell 6 | ONC BeiGene, Ltd. | OYLER JOHN Chief Executive Officer | $15M | 58,590 | |
| 55Moderate | sell 610b5-1 | ONC BeiGene, Ltd. | Wang Xiaodong director, other | $2.1M | 8,146 | |
| 70Notable | sell 6 | ONC BeiGene, Ltd. | OYLER JOHN Chief Executive Officer | $25M | 101,000 | |
| 45Moderate | sell 610b5-1 | ONC BeiGene, Ltd. | Lee Chan Henry SVP, General Counsel | $331k | 1,205 | |
| 75Notable | sell 6 | ONC BeiGene, Ltd. | BAKER BROS. ADVISORS LP director | $191M | 732,827 | |
| 44Moderate | sell 610b5-1 | ONC BeiGene, Ltd. | Lee Chan Henry SVP, General Counsel | $310k | 1,202 | |
| 55Moderate | sell 610b5-1 | ONC BeiGene, Ltd. | Wang Lai Global Head of R&D | $1.3M | 5,000 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.